期刊文献+

高温诱导基质金属蛋白酶9对体外血脑屏障模型claudin-1的影响 被引量:8

Effect of hyperthermia-induced MMP-9 on expression of claudin-1 in in vitro blood brain barrier model
在线阅读 下载PDF
导出
摘要 目的用体外血脑屏障(BBB)模型,研究高温下基质金属蛋白酶9(MMP-9)对BBB微血管内皮细胞紧密连接蛋白claudin-1的影响。方法体外培养大鼠脑微血管内皮细胞和星形胶质细胞,经荧光黄渗透性测定,成功建立体外BBB模型。随机分为常温组(37℃)、高温组(39℃)、常温+MMP-9组(MMP-9 100ng/L)、高温+MMP-9组,并在30、60和90min用通透系数(Pe)值观察通透性变化。用免疫组织化学法和Western blot法检测claudin-1表达。结果高温组较常温组Pe值增加(P<0.05);高温+MMP-9组较上述2组进一步增加(P<0.05)。相同时间点高温组claudin-1阳性细胞较常温组降低(P<0.05)。90min时,高温+MMP-9组claudin-1阳性细胞较高温组降低[(75.0±12.8)个/HP vs(97.0±6.1)个/HP,P<0.05]。高温组claudin-1表达较常温组降低(P<0.05),高温+MMP-9组较相同时间点高温组进一步降低(P<0.05)。结论高温可导致体外BBB模型claudin-1表达下降,BBB通透性增加。外源性添加MMP-9能进一步加剧该损伤,提示高温可通过MMP-9加重BBB破坏。 Objective To study the effect of hyperthermia-induced MMP-9on expression of claudin-1in in vitro BBB model.Methods BMEC and astrocytes were cultured.An in vitro BBB model was established with its permeability assayed by LY test.The BBB model was randomly divided into 37℃ group,39℃ group,37℃+MMP-9group and 39℃+MMP-9group.The permeability of BBB model was recorded at 30,60 and 90min respectively.Expression of claudin-1in BMEC was detected by Western blot with immunocytochemical staining.Results The permeability of BBB model was higher in 39℃ group than in 37℃ group(P〈0.05)and was significantly higher in39℃+MMP-9group than in 37℃ group(P〈0.05).The number of claudin-1positive BMEC was smaller in 39℃+MMP-9group than in 37℃ group at the same time points(P〈0.05)and in 39℃+MMP-9group than in 39℃ group at 90min(75.0±12.8/HP vs 97.0±6.1/HP,P〈0.05).The expression level of claudin-1was lower in 39℃ group than in 37℃ group(P〈0.05)and was significantly higher in 39℃+MMP-9group than in 37℃ group(P〈0.05),which further increased with the increasing time.Conclusion Hyperthermia can downregulate the expression of claudin-1in in vitro BBB model and upregulate the permeability of in vitro BBB model.Adding MMP-9can further aggrevate the damage of in vitro BBB model,indicating that hyperthermia can aggrevate the damage of in vitro BBB model through MMP-9.
出处 《中华老年心脑血管病杂志》 CAS 2017年第9期979-983,共5页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
基金 国家自然科学基金(81460188) 云南省科技计划项目(2011FB148 2013FB201 2013IC041) 云南省中青年学术和技术带头人后备人才培养(2012HB028) 云南省卫生厅卫生系统学科带头人培养计划(D-201235)
关键词 基质金属蛋白酶9 血脑屏障 高温 诱发 内皮细胞 星形细胞 matrix metalloproteinase 9 blood-brain barrier hyperthermia induced endothelial cells astrocytes
作者简介 王利民现在九江市第一人民医院神经内二科工作通信作者:孟强,E—mail:mq301@sina.com.cn
  • 相关文献

参考文献5

二级参考文献161

  • 1刘柳,何远宏,晁志文.进展性脑梗死危险因素的相关性研究[J].临床荟萃,2007,22(9):629-630. 被引量:12
  • 2Wahlgren N, Ahrced N, Davalos A, et al; SITS-MOST Investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITSMOST): an observational study. Lancet, 2007, 369: 275-282.
  • 3Lyden PD, ed. Thrombolytic Therapy for Acute Stroke. 2nd ed. Totowa, NJ: Hmreana Press, 2005.
  • 4Wardlaw JM, Smdercock PA, Berg: E. Throrrbolytic therapy with recoinbinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cunaflative meta-analysis. Stroke, 2003, 34: 1437-1442.
  • 5Wardlaw JM, Zoppo G, Yamaguchi T, et al. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev, 2003, (4): CD000213.
  • 6Shanna M, Clark H, Armour T, et al. Acute stroke: evaluation and treatment. Evid Rep Technol Assess (Sunmm), 2005, (127): 1-7.
  • 7Hill MD, Buchan AM; Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators. Throrrbolysis for acute ischemic stroke: results of the Canadian Altephse for Stroke Effectiveness Study. CMAJ, 20(0, 172: 1307-1312.
  • 8Chung H, Refoios Canto R, Canto RR, et al. Alteplase for the treatment of acute ischaemic stroke: NICE technology appraisal guidance. Heart, 2007, 93: 1616-1617.
  • 9Saver JL, Smith EE, Fonarow GC, et al; GWTG-stroke Steering Committee and Investigators. The "golden hour" and acute brain ischemia: presenting features and lytic therapy in > 30,000 patients ariving within 60 minutes of stroke onset. Stroke, 2010, 41: 1431-1439.
  • 10Scott PA, Xu Z, Meurer WJ, et al. Attitudes and beliefs of Michigan emergmcy physicians toward tissue plasminogen activator use in stroke: baseline survey results from the INcreasing Stroke Treatment through INteractive behavioral Change Tactic (INSTINCT) trial hospitals. Stroke, 2010, 41: 2026-2032.

共引文献1105

同被引文献68

引证文献8

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部